Participants in the study who took an AREDS formulation that included lutein and zeaxanthin, but no beta-carotene, had an 18 percent lower risk of developing advanced AMD over the five years of the study, compared with participants who took the original AREDS formulation with beta-carotene.ДЄlso, AREDS2 participants with low dietary intake of lutein and zeaxanthin at the start of the study were up to 25 percent less likely to develop advanced AMD when taking a daily multivitamin that included 10 mg lutein and 2 mg zeaxanthin, compared with participants with similar dietary intake who did not take a supplement containing lutein and zeaxanthin during the study. Results of the AREDS2 study were published in May 2013.

In particular, lutein and zeaxanthin - plant pigments (carotenoids) that other research suggests may have eye benefits - and omega-3 fatty acids were evaluated.ДЄlso, AREDS2 researchers wanted to evaluate a modification of the original AREDS multivitamin formulation because some research has linked beta-carotene supplementation to increased risk of lung cancer in smokers and previous smokers, and because of concerns about minor side effects such as stomach upset caused by the high amount of zinc in the original AREDS formula among some people. Also, the daily eye supplement had no significant effect on the development or progression of cataract among study participants.Д®ye supplements can help fill in nutritional gaps in a less-than-perfect diet.ДЄREDS2.В AREDS2 was designed to investigate the effect of modifications of the original AREDS supplement formula on the development and progression of AMD and cataracts. Results of the original AREDS were published in 2001 and showed that the antioxidant multivitamin used in the study reduced the risk of AMD progression to advanced stages among people at high risk of vision loss from macular degeneration by about 25 percent.ДЄlso, in the same high-risk group that included participants with intermediate AMD, or advanced AMD in one eye but not the other, the daily multivitamin reduced the risk of vision loss caused by advanced AMD by about 19 percent.ДЇor study participants who had either no AMD or only early AMD, the multivitamin provided no apparent vision benefits.

The multivitamin supplement contained beta-carotene (15 mg), vitamin C (250 mg), vitamin E (400 IU), zinc (80 mg) and copper (2 mg). Most of the study participants already had early or intermediate AMD at the time of enrollment, and the average follow-up period of the study was 6.5 years. clinical trials enrolled several thousand participants and had a follow-up period of at least five years.ДЄREDS.В The original AREDS study investigated the effect of use of a daily multivitamin supplement on the development and progression of AMD and cataracts in a population of approximately 3,600 participants, ages 55 to 80. (AREDS is an acronym for 'Age-Related Eye Disease Study.')Д®ach of these multicenter U.S. Two of the most influential studies of the benefits of eye supplements are the AREDS and AREDS2 studies sponsored by the National Eye Institute. AREDS And AREDS2 - Eye Supplements And Age-Related Eye Disease Taking a daily multivitamin and mineral supplement can help fill in the nutritional gaps in a less-than-optimal diet and may help protect you from degenerative diseases, including eye diseases such as macular degenerationВ and cataracts. Is low in saturated fats, trans fats, cholesterol, salt (sodium) and added sugars.Д«ut it's common knowledge that most Americans don't eat enough fruits, vegetables and other nutrient-rich foods, opting instead for high-calorie, low-nutrient alternatives that can be harmful to the body, including the eyes. Includes lean meats, poultry, fish, beans, eggs and nuts. A diet containing plenty of fruits and vegetables can help you enjoy a lifetime of good vision.Д®mphasizes fruits, vegetables, whole grains and fat-free or low-fat milk and milk products.

Icap vitamin